{"url_path":"/sec/imdx/8-k/2026-06-17/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-029078-index.html","accession_number":"0001493152-26-029078","cik":"0001642380","ticker":"IMDX","issuer_name":"Insight Molecular Diagnostics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-029078-index.html","primary_entity_key":"0001642380","primary_entity_name":"Insight Molecular Diagnostics Inc."},"word_count":477,"has_tables":true,"body_markdown":"**Item\n5.07. Submission of Matters to a Vote of Security Holders.**\n\n \n\n**General**\n\n \n\nThe\nAnnual Meeting was held on June 11, 2026, virtually via live webcast at *https://edge.media-server.com/mmc/p/k94peovi*. Present\nat the Annual Meeting virtually or by proxy were holders of 23,954,212 shares of common stock of the Company, which represented 74.19%\nof the voting power of all shares of common stock of the Company as of April 27, 2026, the record date for the Annual Meeting.\n\n \n\n**Proposals**\n\n \n\nThe\nshareholders of the Company voted on the following proposals at the Annual Meeting, as more fully described in the Proxy Statement:\n\n \n\n \n1.\nTo\nelect the following four (4) director nominees, each to serve until the 2027 annual meeting of shareholders and until his successor\nhas been elected and qualified, or until his earlier death, resignation, or removal: Joshua Riggs, Andrew Arno, Andrew J. Last and\nLouis E. Silverman;\n\n \n\n \n2.\nTo\nratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending\nDecember 31, 2026;\n\n \n\n \n3.\nTo\napprove, on a non-binding advisory basis, the Company’s named executive officer compensation for the year ended December 31,\n2025; and\n\n \n\n \n4.\nTo\napprove an amendment to the Incentive Plan to increase the total number of shares of the Company’s common stock authorized\nfor issuance under the Incentive Plan by 1,750,000, to a total of 5,550,000 shares.\n\n \n\n \n\n \n\n \n\n**Voting\nResults**\n\n \n\nThe\nfinal voting results for each of these proposals at the Annual Meeting are detailed below.\n\n \n\n**1.\nElection of Directors**\n\n \n\n  \n   \nShares Voted \n\nDirector Nominee \nFor  \nAgainst  \nAbstained  \nBroker Non-Votes \n\nJoshua Riggs \n 19,239,253  \n 2,420  \n 3,820  \n 4,708,719 \n\nAndrew Arno \n 19,100,993  \n 140,445  \n 4,056  \n 4,708,719 \n\nAndrew J. Last \n 19,237,621  \n 3,938  \n 3,935  \n 4,708,719 \n\nLouis E. Silverman \n 19,224,148  \n 17,290  \n 4,056  \n 4,708,719 \n\n \n\nBased\non the votes set forth above, each director nominee was duly elected to serve until the 2027 annual meeting of shareholders and until\nhis successor has been elected and qualified, or until his earlier death, resignation, or removal.\n\n \n\n**2.\nRatification of Appointment of Accounting Firm**\n\n \n\n**Shares\nVoted**\n\n**For**\n** **\n**Against**\n** **\n**Abstained**\n** **\n**Broker\nNon-Votes**\n\n23,949,191\n \n2,420\n \n2,601\n \n0\n\n \n\nBased\non the votes set forth above, the shareholders ratified the appointment of CBIZ CPAs P.C. as the Company’s independent registered\npublic accounting firm for the year ending December 31, 2026.\n\n \n\n**3.\nSay On Pay Proposal**\n\n \n\n**Shares\nVoted**\n\n**For**\n** **\n**Against**\n** **\n**Abstained**\n** **\n**Broker\nNon-Votes**\n\n19,199,697\n \n26,126\n \n19,679\n \n4,708,719\n\n \n\nBased\non the votes set forth above, the shareholders approved, on a non-binding advisory basis, the Company’s named executive officer\ncompensation for the year ended December 31, 2025.\n\n \n\n**4.\nApproval of Amendment to Incentive Plan**\n\n \n\n**Shares\nVoted**\n\n**For**\n** **\n**Against**\n** **\n**Abstained**\n** **\n**Broker\nNon-Votes**\n\n19,117,865\n \n122,829\n \n4,799\n \n4,708,719\n\n \n\nBased\non the votes set forth above, the shareholders approved the amendment to the Incentive Plan to increase the total number of shares of\nthe Company’s common stock authorized for issuance under the Incentive Plan by 1,750,000, to a total of 5,550,000 shares."}